© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 9, 639,
May 1, 2002
© 2002 Oxford University Press
IN THIS ISSUE |
In premenopausal women with breast cancer, it is unclear whether the phase of the menstrual cycle in which surgical treatment occurs influences the disease-free and overall survival. Love et al. (p. 662) investigated this question in a population of Chinese and Vietnamese women participating in a randomized clinical trial comparing mastectomy alone with mastectomy plus adjuvant oophorectomy and tamoxifen. The authors found that, for women who received mastectomy alone, the phase of the menstrual cycle did not affect disease-free and overall survival. However,
Interventions for Promoting Pap Testing Among Ethnic Minorities
Hodgkins Lymphoma and Infectious Mononucleosis
p53 Mutations, Lung Cancer Susceptibility, and Ethnicity
Host Circadian Clock and Control of Tumor Progression
Patient Adherence to Oral Drug Therapy